Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joanna Ashton-Chess

Showing results (1-10 of 33) with videos related to

Pageof 4
Sort By:
Journal of Immunological Methods|March 22, 2005
An in vitro evaluation of the potential suitability of peripheral blood CD14(+) and bone marrow CD34(+)-derived dendritic cells for a tolerance inducing regimen in the primateJoanna Ashton-Chess, Gilles Blancho
Personalized Medicine|May 23, 2018
Development of commercial gene-expression-based signatures: review of the scientific strategiesJoanna Ashton-Chess, Alessandra Cl Cervino
Personalized Medicine|May 23, 2018
Company Profile: TcLand ExpressionJoanna Ashton-Chess, Marina Guillet, Alain Huriez
Transplant International : Official Journal of the European Society for Organ Transplantation|June 13, 2006
Is clinical tolerance realistic in the next decade?Joanna Ashton-Chess, Sophie Brouard, Jean-Paul Soulillou
Transplant International : Official Journal of the European Society for Organ Transplantation|September 4, 2008
Can immune monitoring help to minimize immunosuppression in kidney transplantation?Joanna Ashton-Chess, Magali Giral, Jean-Paul Soulillou, et al.
Transplantation|December 1, 2007
Spontaneous operational tolerance after immunosuppressive drug withdrawal in clinical renal allotransplantationJoanna Ashton-Chess, Magali Giral, Sophie Brouard, et al.
Transplantation|February 2, 2011
Elaboration of gene expression-based clinical decision aids for kidney transplantation: where do we stand?Sophie Brouard, Magali Giral, Jean-Paul Soulillou, et al.
Transplantation|May 9, 2009
Using biomarkers of tolerance and rejection to identify high- and low-risk patients following kidney transplantationJoanna Ashton-Chess, Magali Giral, Jean-Paul Soulillou, et al.
Medecine Sciences : M/S|March 5, 2005
[On the acceptability of xenografts]Céline Séveno, Michèle Fellous, Joanna Ashton-Chess, et al.
Expert Review of Clinical Immunology|May 19, 2010
Chronic rejection of human kidney allograftsCaroline Ballet, Magali Giral, Joanna Ashton-Chess, et al.
Pageof 4

Showing results (1-10 of 33) with videos related to

Sort By:
Pageof 4
Journal of Immunological Methods|March 22, 2005
An in vitro evaluation of the potential suitability of peripheral blood CD14(+) and bone marrow CD34(+)-derived dendritic cells for a tolerance inducing regimen in the primateJoanna Ashton-Chess, Gilles Blancho
Personalized Medicine|May 23, 2018
Development of commercial gene-expression-based signatures: review of the scientific strategiesJoanna Ashton-Chess, Alessandra Cl Cervino
Personalized Medicine|May 23, 2018
Company Profile: TcLand ExpressionJoanna Ashton-Chess, Marina Guillet, Alain Huriez
Transplant International : Official Journal of the European Society for Organ Transplantation|June 13, 2006
Is clinical tolerance realistic in the next decade?Joanna Ashton-Chess, Sophie Brouard, Jean-Paul Soulillou
Transplant International : Official Journal of the European Society for Organ Transplantation|September 4, 2008
Can immune monitoring help to minimize immunosuppression in kidney transplantation?Joanna Ashton-Chess, Magali Giral, Jean-Paul Soulillou, et al.
Transplantation|December 1, 2007
Spontaneous operational tolerance after immunosuppressive drug withdrawal in clinical renal allotransplantationJoanna Ashton-Chess, Magali Giral, Sophie Brouard, et al.
Transplantation|February 2, 2011
Elaboration of gene expression-based clinical decision aids for kidney transplantation: where do we stand?Sophie Brouard, Magali Giral, Jean-Paul Soulillou, et al.
Transplantation|May 9, 2009
Using biomarkers of tolerance and rejection to identify high- and low-risk patients following kidney transplantationJoanna Ashton-Chess, Magali Giral, Jean-Paul Soulillou, et al.
Medecine Sciences : M/S|March 5, 2005
[On the acceptability of xenografts]Céline Séveno, Michèle Fellous, Joanna Ashton-Chess, et al.
Expert Review of Clinical Immunology|May 19, 2010
Chronic rejection of human kidney allograftsCaroline Ballet, Magali Giral, Joanna Ashton-Chess, et al.
Pageof 4